Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

This week, he said that his oncologist informed him that delayed thyroid issues can sometimes happen as a result of the treatment he received, and that he now takes medication which has “made a ...

New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...

These effects may lead to hypothyroidism, particularly in individuals who already have thyroid antibodies before starting ...

An overactive thyroid, or hyperthyroidism, has symptoms like fatigue, anxiety, and weight loss. Some things that can cause hyperthyroidism include Grave's disease and thyroiditis. If you don't ...

SGLT2 inhibitors are a new family of agents, which occlude the path of SGLT2 glucose reabsorption and cause glucosuria. Efficacy of SGLT2 inhibitors includes reduction of HbA1c, fasting and ...

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney ... cancer, chemotherapy, thyroid function, and ...